Serum level of YKL-40 does not predict advanced liver fibrosis in children with chronic hepatitis B.

@article{Lebensztejn2007SerumLO,
  title={Serum level of YKL-40 does not predict advanced liver fibrosis in children with chronic hepatitis B.},
  author={Dariusz Marek Lebensztejn and Elżbieta Skiba and Irena Werpachowska and Maria E Sobaniec-Łotowska and Maciej Kaczmarski},
  journal={Advances in medical sciences},
  year={2007},
  volume={52},
  pages={120-4}
}
PURPOSE The aim of the study was to evaluate the serum concentration of YKL-40 (human cartilage glycoprotein-39) in the assessment of fibrosis stage in children compared to biopsy and prior to antiviral treatment for chronic hepatitis B. MATERIAL AND METHODS We determined serum level of YKL-40 (METRA, EIA kit, Quidel Corporation, San Diego, USA) after an overnight fast in 63 children (age range 4-17 years, mean 10 years) with biopsy-verified chronic HBeAg-positive hepatitis B. Fibrosis stage… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 39 references

Effect of antiviral therapy on markers of fibrogenesis in patients with chronic hepatitis C

  • C Nojgaard, JS Johansen, HB Krarup, M Holten-Andersen, F Moller, F Bendtsen
  • Scand J gastroenterol
  • 2003

Similar Papers

Loading similar papers…